AAREY DRUGS & PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]
AAREY DRUGS & PHARMACEUTICALS Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹76 Cr | ₹58 Cr | ₹51 Cr | ₹158 Cr | ₹62 Cr | ₹76 Cr | ₹119 Cr | ₹120 Cr |
Expenses | ₹74 Cr | ₹56 Cr | ₹50 Cr | ₹160 Cr | ₹61 Cr | ₹72 Cr | ₹118 Cr | ₹118 Cr |
Operating Income | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹-2 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹6 Cr | ₹0 Cr | ₹-1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Profit After Tax | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹-1 Cr |
EPS | ₹0.75 | ₹0.31 | ₹0.29 | ₹0.14 | ₹0.39 | ₹0.83 | ₹0.32 | ₹-0.30 |
Industry Peers & Returns | 1W | 1M | 1Y |
AAREY DRUGS & PHARMACEUTICALS | 16.3% | 18.9% | 97.4% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
AAREY DRUGS & PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 32.24 % |
Y-o-Y | 22.42 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹76 Cr | 32.24 | |
Sep2023 | ₹58 Cr | 13.49 | |
Jun2023 | ₹51 Cr | -67.79 | |
Mar2023 | ₹158 Cr | 153.21 | |
Dec2022 | ₹62 Cr | -18.08 | |
Sep2022 | ₹76 Cr | -35.83 | |
Jun2022 | ₹119 Cr | -1.17 | |
Mar2022 | ₹120 Cr | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 46.29 % |
Y-o-Y | 76.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹3 Cr | 46.29 | |
Sep2023 | ₹2 Cr | 37.94 | |
Jun2023 | ₹1 Cr | Positive | |
Mar2023 | ₹-2 Cr | Negative | |
Dec2022 | ₹2 Cr | -64.21 | |
Sep2022 | ₹4 Cr | 374.14 | |
Jun2022 | ₹1 Cr | -51.59 | |
Mar2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.66 % |
Y-o-Y | 44.08 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 3.53% | 10.66 | |
Sep2023 | 3.19% | 21.29 | |
Jun2023 | 2.63% | Positive | |
Mar2023 | -1.38% | Negative | |
Dec2022 | 2.45% | -56.25 | |
Sep2022 | 5.6% | 636.84 | |
Jun2022 | 0.76% | -50.97 | |
Mar2022 | 1.55% | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 143.24 % |
Y-o-Y | 91.27 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹2 Cr | 143.24 | |
Sep2023 | ₹1 Cr | 8.14 | |
Jun2023 | ₹1 Cr | 99.72 | |
Mar2023 | ₹0 Cr | -63.59 | |
Dec2022 | ₹1 Cr | -52.95 | |
Sep2022 | ₹2 Cr | 164.88 | |
Jun2022 | ₹1 Cr | Positive | |
Mar2022 | ₹-1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 83.09 % |
Y-o-Y | 55.63 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 2.49 % | 83.09 | |
Sep2023 | 1.36 % | -4.23 | |
Jun2023 | 1.42 % | 517.39 | |
Mar2023 | 0.23 % | -85.63 | |
Dec2022 | 1.6 % | -42.45 | |
Sep2022 | 2.78 % | 314.93 | |
Jun2022 | 0.67 % | Positive | |
Mar2022 | -0.63 % | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 141.94 % |
Y-o-Y | 92.31 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.75 | 141.94 | |
Sep2023 | ₹0.31 | 6.90 | |
Jun2023 | ₹0.29 | 107.14 | |
Mar2023 | ₹0.14 | -64.10 | |
Dec2022 | ₹0.39 | -53.01 | |
Sep2022 | ₹0.83 | 159.38 | |
Jun2022 | ₹0.32 | Positive | |
Mar2022 | ₹-0.3 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD